Department of Radiology

Publications

2021

Santich BH, Cheal SM, Ahmed M, McDevitt MR, Ouerfelli O, Yang G, et al. A Self-Assembling and Disassembling (SADA) Bispecific Antibody (BsAb) Platform for Curative Two-step Pretargeted Radioimmunotherapy. Clin Cancer Res. 2021;27(2):532-541.

2020

Bellat V, Alcaina Y, Tung C-, Ting R, Michel AO, Souweidane M, et al. A combined approach of convection-enhanced delivery of peptide nanofiber reservoir to prolong local DM1 retention for diffuse intrinsic pontine glioma treatment. Neuro Oncol. 2020;22(10):1495-1504.

Lee SK, Law B, Tung C-. Multifunctional Nanodelivery Platform for Maximizing Nucleic Acids Combination Therapy. Methods Mol Biol. 2020;2115:79-90.

Du B, Tung C-. Enzyme-Assisted Photodynamic Therapy Based on Nanomaterials. ACS Biomater Sci Eng. 2020;6(5):2506-2517.

Gabr MT, Barbault F. First dual binder of microRNA-146a and monomeric tau: a novel approach for multitargeted therapeutics for neurodegenerative diseases. Chem Commun (Camb). 2020;56(67):9695-9698.

Gabr MT, Peccati F. Dual Targeting of Monomeric Tau and α-Synuclein Aggregation: A New Multitarget Therapeutic Strategy for Neurodegeneration. ACS Chem Neurosci. 2020;11(14):2051-2057.

Vedvyas Y, McCloskey JE, Yang Y, Min IM, Fahey TJ, Zarnegar R, et al. Publisher Correction: Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy. Sci Rep. 2020;10(1):12733.

Deh K, Zaman M, Vedvyas Y, Liu Z, Gillen KM, Malley PO, et al. Validation of MRI quantitative susceptibility mapping of superparamagnetic iron oxide nanoparticles for hyperthermia applications in live subjects. Sci Rep. 2020;10(1):1171.

Bellat V, Verchère A, Ashe SA, Law B. Transcriptomic insight into salinomycin mechanisms in breast cancer cell lines: synergistic effects with dasatinib and induction of estrogen receptor β. BMC Cancer. 2020;20(1):661.

Cheal SM, Patel M, Yang G, Veach D, Xu H, Guo H-, et al. An -Acetylgalactosamino Dendron-Clearing Agent for High-Therapeutic-Index DOTA-Hapten Pretargeted Radioimmunotherapy. Bioconjug Chem. 2020;31(3):501-506.